This is consistent with previous immunohistochemistry studies of the TGF-β1 signaling molecule in BRONJ patients showing significantly reduced TGF-β1 and Smad-2/3 in BRONJ patients compared to osteoradionecrosis patients [43]. The gene discussed is TGFB1; the disease is osteoradionecrosis.